ReviewDrug discovery today. Technologies2006
Integration of virtual and physical screening.
Review in Drug discovery today. Technologies, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Diosgenin Promotes Bacterial Clearance in Bladder Epithelial Cells by Regulating Rab27b Expression: A Study Based on Virtual Screening and Experimental Validation.Infection and drug resistance · 2026Article
- Navigating chemical space: multi-level Bayesian optimization with hierarchical coarse-graining.Chemical science · 2025Article
- In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer properties.In silico pharmacology · 2021Article
- The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: fromTherapeutic advances in chronic disease · 2019Review
- High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors.Drug design, development and therapy · 2015Article
- QSAR modeling: where have you been? Where are you going to?Journal of medicinal chemistry · 2014Article
- Adaptation of high-throughput screening in drug discovery-toxicological screening tests.International journal of molecular sciences · 2012Review
- Of possible cheminformatics futures.Journal of computer-aided molecular design · 2012Article
- Drug Repurposing from an Academic Perspective.Drug discovery today. Therapeutic strategies · 2011Article
- Computational systems chemical biology.Methods in molecular biology (Clifton, N.J.) · 2011Review
- Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors.Journal of medicinal chemistry · 2010Article
- Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.Molecular informatics · 2010Article
- Systems chemical biology.Nature chemical biology · 2007Article
- Advances in virtual screening.Drug discovery today. Technologies · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
High-throughput screening (HTS) represents the dominant technique for the identification of new lead compounds in current drug discovery. It consists of physical screening (PS) of large libraries of chemicals against one or more specific biological targets. Virtual screening (VS) is a strategy for
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.